Incannex Healthcare Inc.
	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014	Q1-CY2014	Q4-CY2013
Balance Sheet Date			2025-Jun-30	2025-Mar-31	2024-Dec-31	2024-Sep-30	2024-Jun-30	2024-Mar-31	2023-Dec-31
Fiscal Period			Q4-FY2025	Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024	Q3-FY2024	Q2-FY2024
Total Revenue			0$	0$	12,000$	74,000$	5,800,000$	0$
Cost Of Revenue			0$	0$	0$	0$	0$	18$	12$			0$	0$
Gross Profit			0$	0$	12,000$	74,000$	5,800,000$	(18$)	(12$)			0$	0$
Gross Margin					100.00%	100.00%	100.00%
Operating Expenses			7,528,000$	4,998,000$	5,016,000$	6,328,000$	9,756,000$	7,415,000$	7,983,000$	4,892,000$	4,194,000$	3,638,000$	3,639,000$
Operating Income			(7,528,000$)	(4,998,000$)	(5,004,000$)	(6,254,000$)	(3,956,000$)	(7,415,018$)	(7,983,012$)	(4,892,000$)	(4,194,000$)	(3,638,000$)	(3,639,000$)
Other Income			(24,077,000$)	1,026,000$	(918,000$)	806,000$	(2,515,000$)	1,309,018$	2,722,012$	4,095,000$	(68,000$)	(96,000$)	666,000$
Interest Income			2,000$	4,000$	28,000$	28,000$	40,000$	75,000$	20,000$	71,000$	88,000$	163,000$	55,000$
Interest Expenses
Income Before Tax			(31,603,000$)	(3,968,000$)	(5,894,000$)	(5,420,000$)	(6,431,000$)	(6,031,000$)	(5,241,000$)	(726,000$)	(4,174,000$)	(3,571,000$)	(2,918,000$)
Tax Expenses
Income from Continuing Operations			(31,603,000$)	(3,968,000$)	(5,894,000$)	(5,420,000$)	(6,431,000$)	(6,031,000$)	(5,241,000$)	(726,000$)	(4,174,000$)	(3,571,000$)	(2,918,000$)
Income from Discontinued Operations
Consolidated Income			(31,603,000$)	(3,968,000$)	(5,894,000$)	(5,420,000$)	(6,461,000$)	(6,031,000$)	(5,241,000$)	(726,000$)	(4,174,000$)	(3,571,000$)	(2,918,000$)
Net Income			(31,603,000$)	(3,968,000$)	(5,894,000$)	(5,420,000$)	(6,461,000$)	(6,031,000$)	(5,241,000$)	(726,000$)	(4,174,000$)	(3,571,000$)	(2,918,000$)
Profit Margin					(49,116.67%)	(7,324.32%)	(111.40%)
Earnings to Minority
Earnings to Common Shareholders			(31,603,000$)	(3,968,000$)	(5,894,000$)	(5,420,000$)	(6,461,000$)	(6,031,000$)	(5,241,000$)	(726,000$)	(4,174,000$)	(3,571,000$)	(2,918,000$)
Earnings Per Share, Basic			(0.38$)	(0.20$)	(0.33$)	(0.31$)	(0.38$)	(0.38$)	(0.33$)	(0.05$)		(0.22$)	(0.19$)
Earnings Per Share, Diluted			(0.38$)	(0.20$)	(0.33$)	(0.31$)	(0.38$)	(0.38$)	(0.33$)	(0.05$)		(0.22$)	(0.19$)
Average Shares, Basic			82,917,283	19,632,539	17,624,422	17,642,832	17,038,013	15,873,113	15,873,113	15,873,113		15,873,113	15,398,367
Average Shares, Diluted			82,917,283	19,632,539	17,624,422	17,642,832	17,038,013	15,873,113	15,873,113	15,873,113		15,873,113	15,398,367
EBIT			(31,603,000$)	(3,968,000$)	(5,894,000$)	(5,420,000$)	(6,431,000$)	(6,031,000$)	(5,241,000$)	(726,000$)	(4,174,000$)	(3,571,000$)	(2,918,000$)
EBITDA			(31,542,000$)	(3,973,000$)	(5,768,000$)	(5,356,000$)	(6,369,000$)	(6,014,000$)	(5,241,000$)	(714,000$)	(4,108,000$)	(3,584,000$)	(2,918,000$)

• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation